I am part of Athens LifeTech Park (ALTP), Greece’s first biotech & life sciences park. I focus on partnerships, connecting biotech startups, investors and pharma companies with ALTP’s infrastructure to support R&D scaling and collaboration.
Athens LifeTech Park (ALTP) is Greece’s first dedicated biotechnology and life sciences park, launching in Spata, Attica in 2026. Built around a biotech incubator and an integrated preclinical and early clinical CRO, ALTP offers a credible development environment where highly skilled scientists are genuinely engaged with your program, in one of Europe’s most cost-competitive environments, supporting programs from early discovery through translational development. We are actively seeking collaborations with venture-building VCs, pharma companies and start-ups — if this resonates, we would be glad to connect.
I am part of Athens LifeTech Park (ALTP), Greece’s first dedicated biotechnology and life sciences park. ALTP is built around a biotech incubator and an integrated preclinical and early clinical CRO, designed to support innovation from early discovery through translational development in a highly cost-competitive European environment.
In my role, I focus on partnerships and ecosystem development, working to connect biotech startups, venture-building investors, and pharmaceutical companies with ALTP’s infrastructure and capabilities. My work centers on fostering collaborations that accelerate life sciences innovation and support the successful development and scaling of R&D programs.
I am particularly interested in building strong cross-sector collaborations that bridge science, industry, and investment to advance impactful biotech solutions.
Greece's first dedicated biotechnology and life sciences park, offering an integrated preclinical and early clinical CRO and biotech incubator where highly skilled scientists support programs from early discovery through translational development.
ALTP offers expert-led swine and minipig model services for preclinical drug development — one of Europe's most versatile and translationally relevant large animal platforms, in a cost-competitive EU-regulated environment.